For decades, doctors caring for people with schizophrenia have relied on mood-regulating drugs that target the brain chemical dopamine. On Thursday, the Food and Drug
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in
Pfizer’s decision Wednesday to pull its sickle cell pill off the market because of safety concerns shocked advocates and doctors, leaving many searching for answers
WASHINGTON — Sen. Maggie Hassan (D-N.H.) is pushing to reform Medicare payments to ensure the program pays the same amount for the same services, no
Why are Genentech’s cancer researchers concerned about the direction of the company? What led Pfizer to pull its sickle cell drug off global markets? And
Biden administration officials have abandoned their own proposal to require drug companies to disclose the prices and research costs of drugs that are driving up
Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which
Sohail Djariri, Chief Growth Officer, Sagility Kevin Terrell, Cofounder and CEO, BirchAI, a Sagility company While in recent years healthcare has made significant strides toward
What You Should Know: – Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch
Jae-Eun Lee, CEO and Founder of bitsensing It’s no secret that sleep is crucial for children’s health and academic performance. A good night’s rest enhances